1Subcommittee for scleroderma criteria of the american rheumatism association diagnosis and therapeutic criteria committee. Pretiminary criteria for classtification of systemic sclerosis[J]. Arthritis Rheum,1980,23(5):581-585.
2Spagnolatti L, Zoia MC, Volpini E, et al. Pulmonary function in patients with systemic sclerosis[J]. Monaldi Arch Chest Dis,1997,52(1):4-8.
3Domagala-Kulawik J,Woser G,Doboszynska A,et al.Interstitial lung disease in systemic sclerosis: comparison of BALF lymphocyte phenotype and DLco impairment[J]. Respir Med,1998,92(11):1295-1301.
4Morelli S,Barbieri C,Sgreecia A,et al.Relationship between cutaneous and pulmonary involvement in systemic sclerosis[J].J Rheumatol,1997,24(1):81-85.
5Crestani B,Aubir M.Sclerodermia and alveolar inflammation[J].Rev Mal Respir,1996,13(1):15-20.
6Bolster MB,Ludwicka A,Sutherland SE,et al.Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis[J]. Arthritis Rheum,1997,40(4):743-751.
7Follansbee WP.The cardiovascular manifestations of systemic sclerosis[J]. Current Problemsin Cardiology,1986,11(5):245-290.
